Document Detail


Treatment of Severe Nausea and Vomiting of Pregnancy with Subcutaneous Medications.
MedLine Citation:
PMID:  21667429     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
We examined treatment outcomes in women with severe nausea and vomiting of pregnancy (NVP) receiving outpatient nursing support and either subcutaneous metoclopramide or subcutaneous ondansetron via a microinfusion pump. Among women receiving outpatient nursing services, we identified those diagnosed with severe NVP having a Pregnancy-Unique Quantification of Emesis (PUQE) score of greater than 12 at enrollment and prescribed either metoclopramide ( N = 355) or ondansetron ( N = 521) by their physician. Maternal characteristics, response to treatment, and start versus stop values were compared between the medication groups. Allocation to group was based on intention-to-treat protocol. Maternal characteristics were similar between the groups. Days to reduction in PUQE score levels were similar (median 2 days, metoclopramide; 3 days, ondansetron; P = 0.206). Alteration from metoclopramide to ondansetron (31.8%) was more frequent than alteration from ondansetron to metoclopramide (4.4%; P < 0.001). Improvement of NVP symptoms and reduced need for hospitalization was noted with both medications. Treatment with either metoclopramide or ondansetron resulted in significant improvement of NVP symptoms with half of women showing a reduction from severe symptoms to moderate or mild symptoms within 3 days of treatment initiation. Alteration in treatment was significantly greater in patients initially prescribed metoclopramide.
Authors:
Chad K Klauser; Nathan S Fox; Niki Istwan; Debbie Rhea; Andrei Rebarber; Cheryl Desch; Beverly Palmer; Daniel Saltzman
Related Documents :
21804849 - Self-perceptions in relation to self-reported depressive symptoms in boys and girls.
21802149 - One-year severity of depressive symptoms: results from the nesda study.
23418239 - Treating morning sickness prn?
9606479 - Glucosamine.
22030619 - Life stressors and 5-httlpr interaction in relation to midpregnancy depressive symptoms...
22021869 - Citalopram for major depressive disorder in adults: a systematic review and meta-analys...
10796489 - Lipid-lowering for lower limb atherosclerosis.
893719 - Therapeutic effects of problem-solving training and play-reading groups.
16415629 - Effectiveness of reality therapy program for schizophrenic patients.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-10
Journal Detail:
Title:  American journal of perinatology     Volume:  -     ISSN:  1098-8785     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8405212     Medline TA:  Am J Perinatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© Thieme Medical Publishers.
Affiliation:
Maternal Fetal Medicine Associates, PLLC, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Restrictive Management of Neonatal Polycythemia.
Next Document:  Diagnostic Value of Palpation, Mammography, and Ultrasonography in the Diagnosis of Fibroadenoma: Im...